Inhibition of autophagy via 3-methyladenine alleviates the progression of preeclampsia
Open Access
- 8 July 2024
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 57 (3) , 356-364
Abstract
Autophagy is a cellular mechanism for self-renewal that involves the breakdown of cytoplasmic proteins or organelles within lysosomes. Although preeclampsia (PE) exhibits several characteristics that could imply disrupted autophagy, there is limited evidence supporting the notion that impaired placental autophagy directly causes PE, as indicated by differential expression profiling of whole placental tissue. In our study, we aimed to explore the significance of autophagy in maintaining pregnancy and its association with PE. First, the RNA-seq results showed that 218 genes were differentially expressed in placentas from preeclamptic pregnancies. Notably, KEGG pathway analysis revealed significant enrichment of genes related to autophagy-related signalling pathways, including the PI3K-Akt signalling pathway, the AMPK signalling pathway, and the mTOR signalling pathway. Additionally, our findings indicate an increase in autophagy in placentas from pregnancies complicated by preeclampsia as well as in trophoblasts subjected to hypoxic conditions. Next, we examined the impact of 3-methyladenine (3-MA), a targeted inhibitor of autophagy, on the progression of PE. The administration of 3-MA profoundly alleviated the severity of PE-like symptoms in rats subjected to reduced uterine perfusion pressure (RUPP). These findings from our study suggest that inhibiting autophagy may serve as a promising approach for adjuvant chemotherapy for PE.Keywords
This publication has 32 references indexed in Scilit:
- Nutrient-sensing AgRP neurons relay control of liver autophagy during energy deprivationCell Metabolism, 2023
- Pretreatment with 3-methyladenine ameliorated Pseudomonas aeruginosa-induced acute pneumonia by inhibiting cell death of neutrophils in a mouse infection modelInternational Journal of Medical Microbiology, 2023
- Effects of 3-methyladenine, an autophagy inhibitor, on the elevated blood pressure and arterial dysfunction of angiotensin II-induced hypertensive miceBiomedicine & Pharmacotherapy, 2022
- The placenta and preeclampsia: villain or victim?American Journal of Obstetrics and Gynecology, 2022
- Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomicsAgeing Research Reviews, 2021
- Inhibition of autophagy by 3‐methyladenine restricts murine cytomegalovirus replicationJournal of Medical Virology, 2021
- The Inhibition of Protein Kinase C β Contributes to the Pathogenesis of Preeclampsia by Activating AutophagyEBioMedicine, 2020
- Biological Functions of Autophagy Genes: A Disease PerspectiveCell, 2019
- Silencing H19 regulated proliferation, invasion, and autophagy in the placenta by targeting miR‐18a‐5pJournal of Cellular Biochemistry, 2018
- Severe preeclampsia: what’s new in intensive care?Intensive Care Medicine, 2015